John M. Leonard
President and CEO at Intellia Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Intellia Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
IQVIA Holdings Inc. April 23, 202697.1%
-
Intellia Therapeutics Inc. June 11, 202597.8%
-
IQVIA Holdings Inc. April 24, 202598.6%
-
IQVIA Holdings Inc. April 16, 202497.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Intellia Therapeutics Inc. | Open-market sale | −9,000 | $11.99 | $107,910 |
| Aug 21, 2026 | Intellia Therapeutics Inc. | Open-market sale | −2,785 | $13.00 | $36,205 |
| Aug 20, 2026 | Intellia Therapeutics Inc. | Open-market sale | −19,890 | $12.60 | $250,614 |
| Apr 23, 2026 | IQVIA Holdings Inc. | Grant or award | +1,571 | — | — |
| Mar 1, 2026 | Intellia Therapeutics Inc. | Grant or award | +156,400 | — | — |
| Jan 5, 2026 | Intellia Therapeutics Inc. | Open-market sale | −34,146 | $9.21 | $314,485 |
| Dec 12, 2025 | Intellia Therapeutics Inc. | Option exercise | +8,557 | $6.83 | $58,444 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Option exercise | +49,959 | $6.83 | $341,220 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Open-market sale | −49,959 | $9.49 | $474,111 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Open-market sale | −32,832 | $9.47 | $310,919 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Open-market sale | −5,355 | $9.59 | $51,354 |
| Apr 24, 2025 | IQVIA Holdings Inc. | Grant or award | +1,592 | — | — |
| Mar 1, 2025 | Intellia Therapeutics Inc. | Grant or award | +136,000 | — | — |
| Jan 3, 2025 | Intellia Therapeutics Inc. | Open-market sale | −26,807 | $12.18 | $326,509 |
| Jan 1, 2025 | Intellia Therapeutics Inc. | Option exercise | +7,850 | — | — |
Questions about John M. Leonard
What boards is John M. Leonard on?
John M. Leonard sits on the boards of IQVIA Holdings Inc. and Intellia Therapeutics Inc.
What company is John M. Leonard the CEO of?
John M. Leonard is President and CEO of Intellia Therapeutics Inc.
How long has John M. Leonard served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.